89 related articles for article (PubMed ID: 32457407)
1. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).
Chu YH; Dias-Santagata D; Farahani AA; Boyraz B; Faquin WC; Nosé V; Sadow PM
Mod Pathol; 2020 Nov; 33(11):2186-2197. PubMed ID: 32457407
[TBL] [Abstract][Full Text] [Related]
2. NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas.
Lee SE; Lee MS; Bang H; Kim MY; Choi YL; Oh YL
Mod Pathol; 2023 Aug; 36(8):100180. PubMed ID: 37003481
[TBL] [Abstract][Full Text] [Related]
3. Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
Syed AR; Gorana A; Nohr E; Yuan XK; Amin MASc P; Ghaznavi S; Lamb D; McIntyre J; Eszlinger M; Paschke R
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642578
[TBL] [Abstract][Full Text] [Related]
4. Primary NTRK -rearranged Spindle Cell Neoplasm of the Gastrointestinal Tract: A Clinicopathological and Molecular Analysis of 8 Cases.
Gao X; Xu S; Zhu P; Lao IW; Yu L; Wang J
Am J Surg Pathol; 2024 May; 48(5):623-631. PubMed ID: 38525823
[TBL] [Abstract][Full Text] [Related]
5. A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma.
Germani MM; Boccaccio C; Matrone A; Molinaro E; Alì G; Giordano M; Elisei R; Fontanini G; Cremolini C
Oncologist; 2024 Jan; 29(1):84-88. PubMed ID: 38037189
[TBL] [Abstract][Full Text] [Related]
6. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
[TBL] [Abstract][Full Text] [Related]
8. How Sensitive is Pan-TRK Immunohistochemistry for Detecting NTRK Fusions in Papillary Thyroid Carcinoma?
Hang JF; Lee YC
Mod Pathol; 2023 Jul; 36(7):100222. PubMed ID: 37336120
[No Abstract] [Full Text] [Related]
9. Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.
Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
Oncotarget; 2024 Feb; 15():106-116. PubMed ID: 38329731
[TBL] [Abstract][Full Text] [Related]
10. NTRK-rearranged spindle cell neoplasm: Initial observation of imaging appearance and clinicopathologic correlation.
Spano M; Davis-Hayes C; Hameed M; Benayed R; Hwang S
Clin Imaging; 2024 Jun; 110():110134. PubMed ID: 38631176
[TBL] [Abstract][Full Text] [Related]
11. Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions.
de Castro JVA; Dos Santos PJS; Mantoan H; Baiocchi G; Bovolim G; Torrezan G; Corassa M; do Nascimento AG; De Brot M; Costa FD; De Brot L
Int J Gynecol Pathol; 2024 Jan; 43(1):56-60. PubMed ID: 37668341
[TBL] [Abstract][Full Text] [Related]
12. ETV6::NTRK3 gene fusion in a patient with metastatic lung atypical carcinoid successfully treated with repotrectinib: A case report.
Gao L; Ai X; Lu S
Lung Cancer; 2024 Jan; 187():107443. PubMed ID: 38113652
[TBL] [Abstract][Full Text] [Related]
13. [NTRK-rearranged spindle cell neoplasm: report of a case].
Wei X; Wu HY; Pu XH; Wang XD; Li ZW; Sun Q
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1278-1280. PubMed ID: 38058049
[TBL] [Abstract][Full Text] [Related]
14. [NTRK-rearranged uterine sarcoma: a clinicopathological analysis of seven cases].
Huang HJ; Wang C; Fan DG; He YH; Chen X; Zheng SL
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):189-191. PubMed ID: 38281791
[No Abstract] [Full Text] [Related]
15. Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic.
Cao Q; Huang Z; Liang H; Hu X; Wang L; Yang Y; Lian B; Huang J; Guo J
Front Oncol; 2024; 14():1308916. PubMed ID: 38357202
[TBL] [Abstract][Full Text] [Related]
16. NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report.
Palmerini E; Frega G; Gambarotti M; Frisoni T; Cesari M; Bazzocchi A; Miceli M; Donati DM; Fanti S; Nanni C; Benini S; Longhi A; Paioli A; Marrari A; Hakim R; Righi A; Ibrahim T
Front Oncol; 2023; 13():1252359. PubMed ID: 37876963
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of NTRK-rearranged spindle cell neoplasms of the uterus of two cases].
Hu GM; Chen HP; Zhang RZ; Wu HF
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):480-482. PubMed ID: 38678330
[No Abstract] [Full Text] [Related]
18. Uterine Neurotrophic Tyrosine Receptor Kinase Rearranged Spindle Cell Neoplasms: Three Cases of an Emerging Entity.
Grant L; Boyle W; Williams S; Pascoe J; Ganesan R
Int J Gynecol Pathol; 2023 Sep; ():. PubMed ID: 37922944
[TBL] [Abstract][Full Text] [Related]
19. Entrectinib for NTRK Fusion-Positive Metastatic Melanoma Progressing on Combined PD-1 and CTLA-4 Inhibition: A Case Report.
Dawood S; Ali ZJ
Case Rep Oncol; 2023; 16(1):1451-1459. PubMed ID: 38028569
[TBL] [Abstract][Full Text] [Related]
20. Kinase Fusion-Related Thyroid Carcinomas: Towards Predictive Models for Advanced Actionable Diagnostics.
Chu YH; Sadow PM
Endocr Pathol; 2022 Dec; 33(4):421-435. PubMed ID: 36308634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
